Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Yonghe Medical Group Co., Ltd. ( (HK:2279) ) has provided an announcement.
Yonghe Medical Group has issued a positive profit alert, indicating it expects to report net profit of at least RMB70 million for 2025, reversing a net loss of about RMB226.6 million in 2024. The turnaround is underpinned by a refined clinic network deployment, improved resource allocation, and the integration of its Hefan medical management system with AI tools to raise efficiency, quality control, and cost management, driving an anticipated 5.5 to 6.5 percentage‑point increase in gross margin.
The group has also pushed restructuring of its management model and sharpened its marketing strategies, which has boosted customer conversion and marketing returns while streamlining its organizational and cost structure. As a result, selling and marketing expenses and general and administrative expenses as a share of operating income are expected to fall by 5.0 to 6.0 percentage points and 2.0 to 3.0 percentage points respectively, signaling sustained earnings momentum and stronger operational leverage, though the figures remain based on unaudited management accounts and may change when final results are released by end‑March 2026.
More about Yonghe Medical Group Co., Ltd.
Yonghe Medical Group Co., Ltd. is a Hong Kong‑listed medical services provider operating a network of clinics, with a focus on optimizing resource allocation and deploying intelligent, self‑developed medical chain management systems to enhance diagnosis, treatment, and operational efficiency across its healthcare operations.
Average Trading Volume: 225,980
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.07B
Learn more about 2279 stock on TipRanks’ Stock Analysis page.